Valuation : Acarix AB

Market Cap 302M 31.48M 27.18M 25.48M 23.27M 43.8M 3B 43.99M 118M 1.52B 118M 116M 5.08B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 302M 31.48M 27.18M 25.48M 23.27M 43.8M 3B 43.99M 118M 1.52B 118M 116M 5.08B EV / Sales 2026 *
21.6x
EV / Sales 2027 * 9.44x
Free-Float
79.69%
Yield 2026 *
-
Yield 2027 * -
1 day+1.46%
1 week+4.06%
Current month-3.37%
1 month-1.42%
3 months-5.98%
6 months-14.26%
Current year-9.14%
1 week 0.23
Extreme 0.2285
0.25
1 month 0.23
Extreme 0.2285
0.27
Current year 0.22
Extreme 0.2245
0.33
1 year 0.22
Extreme 0.2245
0.35
3 years 0.17
Extreme 0.1688
0.6
5 years 0.17
Extreme 0.1688
1.58
10 years 0.17
Extreme 0.1688
26.8
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+4.06%-11.45%-44.66% 31.29M
+1.24%+1.85%+31.04%-26.86% 17.96B
-0.71%-2.30%-25.51%+101.29% 1.66B
-3.79%-0.74%-46.92%-80.88% 1.05B
+0.61%-1.78%-25.37%+24.44% 959M
+0.05%+0.05%+61.57%-5.56% 779M
-3.02%-4.58%-35.97%-46.09% 693M
+0.18%-2.01%-42.83%-48.50% 565M
+0.67%+5.05%-37.84%-32.89% 461M
-3.33%+3.67%+70.32%+48.82% 459M
Average -0.66%+3.04%-6.30%-11.09% 2.46B
Weighted average by Cap. +0.59%+1.52%+18.47%-17.61%

Financials

2026 *2027 *
Net sales 14M 1.46M 1.26M 1.18M 1.08M 2.03M 139M 2.04M 5.47M 70.42M 5.48M 5.36M 235M 32M 3.34M 2.88M 2.7M 2.46M 4.64M 318M 4.66M 12.49M 161M 12.52M 12.25M 538M
Net income -30.8M -3.21M -2.77M -2.6M -2.37M -4.47M -306M -4.49M -12.02M -155M -12.05M -11.79M -518M -15.3M -1.59M -1.38M -1.29M -1.18M -2.22M -152M -2.23M -5.97M -76.96M -5.99M -5.86M -257M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
26-08-28 SEK 0.2435 +1.46% 157,007
26-08-27 SEK 0.2400 -3.03% 664,332
26-08-26 SEK 0.2475 +2.91% 985,473
26-08-25 SEK 0.2405 +3.22% 733,422
26-08-24 SEK 0.2330 0.00% 583,159

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ACARIX Stock